22-30468681-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_174975.5(SEC14L3):āc.250A>Cā(p.Met84Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0002 in 1,613,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_174975.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEC14L3 | NM_174975.5 | c.250A>C | p.Met84Leu | missense_variant | 5/12 | ENST00000215812.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEC14L3 | ENST00000215812.9 | c.250A>C | p.Met84Leu | missense_variant | 5/12 | 1 | NM_174975.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251138Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135680
GnomAD4 exome AF: 0.000209 AC: 306AN: 1461466Hom.: 0 Cov.: 41 AF XY: 0.000197 AC XY: 143AN XY: 726950
GnomAD4 genome AF: 0.000105 AC: 16AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2023 | The c.250A>C (p.M84L) alteration is located in exon 5 (coding exon 5) of the SEC14L3 gene. This alteration results from a A to C substitution at nucleotide position 250, causing the methionine (M) at amino acid position 84 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at